Attached files

file filename
EX-99.1 - EX-99.1 - Orthofix Medical Inc.a12-5629_1ex99d1.htm

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 


 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): February 23, 2012

 


 

Orthofix International N.V.

(Exact name of Registrant as specified in its charter)

 

Curaçao

 

0-19961

 

N/A

(State or other jurisdiction of incorporation)

 

(Commission File Number)

 

(IRS Employer Identification No.)

 

7 Abraham de Veerstraat

Curaçao

 

N/A

(Address of principal executive offices)

 

(Zip Code)

 


 

Registrant’s telephone number, including area code: 011-59-99-465-8525

 


 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

o            Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 



 

Item 2.02.                                          Results of Operations and Financial Conditions

 

On February 23, 2012, Orthofix International N.V. (the “Company”) issued a press release (the “press release”) announcing, among other things, its results for the fourth quarter ended December 31, 2011.  A copy of the press release is furnished herewith as Exhibit 99.1 and attached hereto.

 

Item 9.01.              Financial Statements and Exhibits

 

(d)                                 Exhibits

 

99.1                           Press release of Orthofix International N.V. dated February 23, 2012.

 

2



 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

 

Orthofix International N.V.

 

 

 

 

By:

/s/ Brian McCollum

 

 

Brian McCollum
Chief Financial Officer and
Senior Vice President of Finance

 

 

Date: February 23, 2012

 

3



 

EXHIBIT INDEX

 

Exhibit No.

 

Description

 

 

 

99.1

 

Press release, dated February 23, 2012

 

4